Exclusion Criteria:~1. A diagnosis of vascular dementia or dementia by other cause according to the criteria of
the NINCDS-ADRDA~2. Structural brain abnormality or impairment~3. Schizophrenia, depressive disorder and
bipolar disorder~4. Any neurological disease except Alzheimer' disease (ex. Parkinson's disease, Huntington's
disease, brain tumor, normal-pressure hydrocephalus, progressive supranuclear palsy, seizure disorder, subdural
hematoma, multiple sclerosis, epilepsy, delusion and head injury required hospitalization)~5. History of any
cancer within previous 5 years~6. History of stroke within previous 2 years~7. Heart failure required
medication or interventional treatment including myocardial infarction, valvular heart disease, arrhythmia
within previous 1 year~8. Uncontrollable diabetes~9. Uncontrollable hypertension~10. Abnormal liver or kidney
function~11. Patient with significant clinical meaning to affect cognitive function~12. Patient who
participated in other clinical trial within previous 3 months or has a plan to participate in other clinical
trial during study period~13. History of abuse of a drug or alcohol within previous 2 years~14. Patient who has
administrated other acetylcholinesterase inhibitors except donepezil within previous 4 weeks~15. Patient who
are deemed inadequate to participate in the clinical trial by the investigator(ex. a illiteracy, etc.)~16.
History of hypersensitivity reaction to the main ingredient of the investigational drugs~17. Patient who has
administrated other drugs except donepezil for dementia treatment (it is possible to enroll after washout for
28 days)
